Liqun Zou
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Leukemia | Phase 1 | 2021-03-17 |